Gliptin treatment tied to higher risk of acute pancreatitis
(HealthDay)—Gliptin treatment is associated with increased acute pancreatitis risk, according to research published online Sept. 22 in Diabetes Care.
Sep 27, 2016
0
1
(HealthDay)—Gliptin treatment is associated with increased acute pancreatitis risk, according to research published online Sept. 22 in Diabetes Care.
Sep 27, 2016
0
1
Larry Jacob got the call every parent fears. His daughter was sick, away at college and needed help. Mr. Jacob left his home in the Chicago suburbs and was driving to Western Illinois University when he suddenly doubled over ...
Sep 15, 2016
0
0
Extensive population-based studies on a popular group of drugs used to treat type 2 diabetes revealed no association with acute pancreatitis, but increased risk of bile duct and gallbladder disease
Aug 2, 2016
0
19
Researchers have identified a rare genetic variation associated with a dramatically increased risk of severe acute pancreatitis in acute lymphoblastic leukemia (ALL) patients treated with the chemotherapy agent asparaginase. ...
Apr 25, 2016
0
1
Patients suffering organ failure caused by a common inflammatory condition could be helped by a new therapy.
Jan 11, 2016
0
85
The burden of recurrent acute and chronic pancreatitis in children may be higher than previously thought, with high costs related to repeated hospitalizations, report a pair of studies in the Journal of Pediatric Gastroenterology ...
Jan 4, 2016
0
2
Idiopathic pancreatitis is often caused by small gallstones that are difficult to observe prior to surgery, shows a study from the University of Eastern Finland. Small gallstones were found in surgery from two out of three ...
Dec 7, 2015
0
23
Researchers at Lund University in Sweden may have discovered one of the keys to understanding how the body develops acute pancreatitis. The results offer hope for the development of drugs that specifically target the disease.
Sep 8, 2015
0
8
The pancreas is a tricky organ for researchers and surgeons alike because of its sensitivity. Tucked away in a hard-to-reach spot behind the stomach, it's in charge of secreting enzymes to help digest everything you eat. ...
Jun 12, 2015
0
16
A clinical trial of the glucose-control drug sitagliptin among patients with type 2 diabetes and established cardiovascular disease has found it did not raise the risk of major adverse cardiovascular events.
Jun 9, 2015
0
16